In September 2016, women leaders in hepatitis convened for Women in High Places: Leading the Global Challenge of Hepatitis and Liver Cancer Control in New York City. Women in High Places (WIHP) is a network of global women leaders in medicine, academic research, government, industry, and consumer or patient advocacy, with a common interest in special diseases. Read More→
On July 27, Innovara and the Korean Research-based Pharmaceutical Industry Association (KRPIA) jointly hosted the Inaugural Meeting of Women in High Places: Leading the Global Challenge of Medicine (“WIHP”). The meeting opened by welcoming remarks by Oak Yeon Kim, President of KRPIA. Congresswoman Dr. InSook Park (Sanuri Party, head of Healthcare and Welfare Committee) also joined the meeting to greet and welcome the women leaders after Ms. Read More→
Barri Blauvelt, CEO of Innovara, and Kyung Hee Choi, VP of Asian Health Services at Holy Name Medical Center, have created quite a buzz recently with their collaboration on Patient Centered Cultural Intelligence, or PCCQ. PCCQ brings together the concept of patient-centered care and culturally competent care to improve patient experience, Read More→
The rapid pace of innovation in technology is driving our personal and work lives faster and faster every day. There are many great advances, with new tools and solutions everywhere we turn. No matter how much technology and math you use, the “high tech” will eventually need to turn over to “high touch”. Read More→
Recently, a CEO of a start-up life-sciences company and I were reviewing the company’s branding strategy. I listened to him discuss his company and its first brand to be launched. I reviewed the company’s website and all the PowerPoint presentations and executive overview. Then I asked him a question: What is your brand’s essence? Read More→
We’ve all heard the term, “Upstream Marketing.” For years we have been assessing the understanding of this among healthcare marketing executives. I have come to realize recently that few really understand how it not only applies to disease, but also to healthcare marketing. Some think it is related to a tough challenge, Read More→
There are many win-win business opportunities for the pharmaceutical industry and people in emerging and new markets around the world. One win-win opportunity is the development of key relationships with thought leaders who are in positions of power and influence in medicine, advocacy, policy and so on. This entails getting to know the key thought leaders in these markets and establishing the trust that the company is making a true commitment. Read More→
Achieving Health and Business Outcomes: The Synergy of Combining Strategic Insight Research™ (SIR™) with Epidemiology Research and ScoreCard Modelling™
How can a company ensure that the medical products and services it offers will be able to cascade effectively to improve the health of patients and health outcomes?
To succeed, go back to the beginning. Companies not only require dependable and current epidemiology (how real is the need, Read More→
Running a strategic insights market research project internationally can be quite a daunting task. There are a number of challenges that you will face that are different from a domestic project. These include legal, language, time, physical location, and cultural barriers.
First of all, Read More→